Literature DB >> 28358846

Risk factors associated with Tuberculosis (TB) among people living with HIV/AIDS: A pair-matched case-control study in Guangxi, China.

Zhezhe Cui1, Mei Lin1, Shaofa Nie2, Rushu Lan1.   

Abstract

BACKGROUND: As one of the poorest provinces in China, Guangxi has a high HIV and TB prevalence, with the annual number of TB/HIV cases reported by health department among the highest in the country. However, studies on the burden of TB-HIV co-infection and risk factors for active TB among HIV-infected persons in Guangxi have rarely been reported.
OBJECTIVE: To investigate the risk factors for active TB among people living with HIV/AIDS in Guangxi Zhuang autonomous region, China.
METHODS: A surveillance survey was conducted of 1 019 HIV-infected patients receiving care at three AIDS prevention and control departments between 2013 and 2015. We investigated the cumulative prevalence of TB during 2 years. To analyze risk factors associated with active TB, we conducted a 1:1 pair-matched case-control study of newly reported active TB/HIV co-infected patients. Controls were patients with HIV without active TB, latent TB infection or other lung disease, who were matched with the case group based on sex and age (± 3 years).
RESULTS: A total of 1 019 subjects were evaluated. 160 subjects (15.70%) were diagnosed with active TB, including 85 clinically diagnosed cases and 75 confirmed cases. We performed a 1:1 matched case-control study, with 82 TB/HIV patients and 82 people living with HIV/AIDS based on surveillance site, sex and age (±3) years. According to multivariate analysis, smoking (OR = 2.996, 0.992-9.053), lower CD 4+ T-cell count (OR = 3.288, 1.161-9.311), long duration of HIV-infection (OR = 5.946, 2.221-15.915) and non-use of ART (OR = 7.775, 2.618-23.094) were independent risk factors for TB in people living with HIV/AIDS.
CONCLUSION: The prevalence of active TB among people living with HIV/AIDS in Guangxi was 173 times higher than general population in Guangxi. It is necessary for government to integrate control planning and resources for the two diseases. Medical and public health workers should strengthen health education for TB/HIV prevention and treatment and promote smoking cessation. Active TB case finding and early initiation of ART is necessary to minimize the burden of disease among patients with HIV, as is IPT and infection control in healthcare facilities.

Entities:  

Mesh:

Year:  2017        PMID: 28358846      PMCID: PMC5373582          DOI: 10.1371/journal.pone.0173976

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Tuberculosis (TB) and human immunodeficiency virus (HIV) co-infection is a severe public health problem around the world [1-2]. Beginning in the 1980’s, the epidemic of AIDS has accelerated the rates of transmission and mortality due to TB. The rate of TB/HIV co-infection peaked in the 1990’s. With the implementation of antiretroviral treatment (ART), the incidence of TB has decreased slowly. Unfortunately, globalization with economic and cultural exchanges has contributed disease spread in recent years[3]. The increased trend of TB/HIV co-infection is approximately 10% per year[4]. In 2014, almost 1.2 million cases (12.5%) of TB worldwide were associated with HIV infection, and TB accounts for an estimated 350,000 deaths among HIV-infected persons. Asia has a high-prevalence area of TB/HIV co-infection second to Africa[5]. The prevalence of HIV infection in the Asia-Pacific region (including China) is at medium level (0.09%). The number of HIV/AIDS cases in China has increased since the first case was identified in 1985, although the prevalence rate is relatively low (< 0.09%). However, the burden of TB in China is heavy. According to World Health organization (WHO)[4], the TB cases reported from China was the third highest globally in 2014, following India and Indonesia. As one of the poorest provinces in China, Guangxi is also regarded as a high HIV and TB prevalence area, where the annual number of TB/HIV cases reported by health department is the largest in China[6-7]. However, studies of the burden of TB-HIV co-infection and the risk factors for active TB among HIV-infected persons in Guangxi have rarely been reported. For this reason, we investigated the prevalence and risk factors for active TB among people living with HIV/AIDS receiving care in three AIDS prevention and control departments in higher HIV prevalence cities in Guangxi.

Methods

Study population and diagnostic methods

The study population was composed of 1 019 people living with HIV/AIDS who received care at three AIDS prevention and control departments between 2013 and 2015. A surveillance survey was conducted using questionnaire(collecting demographic behavioral and clinical characteristics), medical records review(collecting HIV testing information, latest CD4+ T-cell count, ART status and therapeutic schedule) and TB screening[including symptom screen, image examination (IE), Interferon-Gamma Release Assays (IGRAs)[8], sputum culture, drug sensitivity testing and Xpert MTB/RIF Assay[9]. Unfortunately, we haven’t access to the information of viral load determination because of the shortage of reagent at the time of the study. MTB infection case was defined by IGRAs positive. Clinically diagnosed active TB case was defined by IE and TB symptom positive. Confirmed active TB was diagnosed by direct detection methods, including sputum culture or Xpert MTB/RIF Assay or histopathological examination of non-sputum specimens. All study patients provided three sputum samples (one spot sample, one morning sample and another evening sample) for bacteriological examination and whole blood (more than 4 ml) for IGRAs. (Fig 1).
Fig 1

The program of information collection and TB screen among HIV/AIDS.

Study design and variables

We analyzed the cumulative prevalence of active TB (included clinically diagnosed and confirmed cases) among 1 019 people living with HIV/AIDS during the study period. To survey factors associated with occurrence of active TB in people living with HIV/AIDS, we performed a 1:1 matched case-control study. The case group included 82 HIV-infected patients with active TB, after exclusion of 10 subjects who were unwilling, 8 subjects unable to participate in this project with mental disease or severe complication, 1 subjects who died at the time being diagnosed active TB and 59 subjects who could not be matched 1:1 with controls in their surveillance site. All subjects in the case group had TB newly diagnosed during the research period. The control group consisted of 82 HIV-infected patients without active TB or latent mycobacterium tuberculosis infection (LTBI) or other lung disease, who were matched with the case group based on surveillance site, sex and age (±3) years for avoiding confounding. The following variables were also assessed: demographic characteristics (occupation, Ethnicity, education status, marital status, place of residence, local residence duration, household income per capita, number of family members), behavioral characteristics (history of close contact with TB patient, history of BCG vaccination, history of former plasma donors, history of intravenous drug abuse, HIV infection status of regular sex partner, extramarital sex, condom use, history of alcohol use, history of cigarette smoking), clinical characteristics [body mass index (BMI), chronic disease, latest CD 4+ T-cell count, HIV risk factors, use of ART, duration of HIV infection].

Statistical analysis

Categorical data were analyzed using independent sample Chi-square tests and Continuous variables were analyzed using independent sample t tests. A conditional logistic regression analysis was used to avoid effects of confounding variables for active TB. For this analysis, those variables with P < 0.05 on the univariate analysis were entered into the multivariate analysis model. For stepwise multivariate analysis, if there was significant correlation between independent variables, only one was entered into the model to avoid multicollinearity. Variables with a significant association in bivariate analysis were included in a final logistic regression model. All P values were two-tailed, and P < 0.05 was considered statistically significant. Odds ratios (OR) and their 95% confidence intervals (CIs) were estimated using conditional logistic regression, with TB as an outcome. All of the statistical analyses were performed using Epi-Info (version 6, CDC, Atlanta, GA) and IBM SPSS statistical data editor (version 19, Statistical Product and Service Solutions, Chicago, IL). This research was approved by the Institutional Review Board of the Guangxi (IRB 0001594, FWA 00001359). Ethics committees approve this consent procedure. All participants provided their written informed consent to participate in this study.

Results

Population of TB Surveillance

The mean age of the 1 019 HIV-infected patients enrolled was 48.97±14.44 years (mean ± standard deviation) (range 19~85). Sex ratio was 2.33: 1 (male/female). The majority of subjects reported their occupation as farmers (61.3%), followed by unemployed (14.3%). The median of household income per capita was 5 582.63 Yuan per year (range 77~50 000 Yuan py). The median of BMI was 20.46 (range 12.3–41.7). The median of latest CD 4+ T-cell count was 235.68 cells/mm3 (range 2–1610). The percentage of individuals who reported opportunistic infection symptoms was 26.4%. Only 47.5% of the subjects had received ART before the study period (Table 1).
Table 1

HIV/AIDS cohort description.

CharacteristicSubjects(n = 1 019) mean±SD or n(%)
Gender
    Male713(69.97)
    Female306(30.03)
Age(years)48.97±14.44
Ethnicity
    Han590(57.90)
    Zhuang418(41.02)
    Other11(1.08)
Education status
    Illiterate102(10.01)
    Primary school409(40.14)
    Junior middle school414(40.62)
    Above high school94(9.22)
Marital status
    Married735(72.13)
    other284(27.87)
Household incomes per capita,Yuan5 582.63±4881.30
BMI20.46±2.87
Latest CD 4+ T-cell count, cells/mm3235.68±153.26
Status of ART
    Have access to ART484(47.50)
    Haven't access to ART535(52.50)
Opportunistic infections symptoms
    Yes269(26.40)
    No750(73.60)

Cumulative prevalence of active tuberculosis among people living with HIV/AIDS

Over a total of 1 019 of subjects, 160 subjects (15.70%) were diagnosed with active TB, including 85 clinically diagnosed cases (1 patient at the time being diagnosed active TB) and 75 confirmed cases (72 pulmonary TB and 3 extrapulmonary). The detection rate of latent mycobacterium tuberculosis infection (LTBI) was 15.30% detected by IGRAs. In addition, we found 54 subjects with NTM infection.

Characteristics and risk factors for active tuberculosis among people living with HIV/AIDS

In this case-control study, the mean age of HIV-infected individuals with active TB was 47.95 ± 14.13 years, and 89.02% of the subjects were male. The mean duration of HIV-infection was 7.30 ± 3.53 years. The mean of BMI was 19.19 ± 2.46. The mean of latest CD 4+ T-cell count was 188.78 ± 235.95 cells/mm3 (Table 2).
Table 2

Baseline characteristic of cases and controls.

CharacteristicCases(n = 82) mean±SD or n(%)Controls(n = 82) mean±SD or n(%)
Age at baseline, years47.95 ± 14.1348.04±14.18
Sex
    Male73(89.02)73(89.02)
    Female9(10.98)9(10.98)
Duration of HIV-infection, years7.30±3.536.09±3.09
BMI, kg/m319.19±2.4619.70±2.69
Latest CD 4+ T-cell count, cells/mm3188.78±235.95217.66±189.93
On univariate analysis of demographic variables, there were no statistically significant variables associated with active TB. On analysis of behavioral variables, HIV infection status of regular sex partner (P = 0.047, OR = 1.361, 95% confidence interval [CI]: 1.004–1.844), history of smoking (P = 0.023, OR = 2.273, 95% CI: 1.118–6.419) were significantly associated with active TB. On analysis of clinical variables, BMI (P = 0.044, OR = 0.553, 95% CI: 0.311–0.984), latest CD 4+ T-cell count (P = 0.002, OR = 3.714, 95% CI: 1.612–8.577), status of ART use (P = 0.000, OR = 3.889, 95% CI: 1.869–8.090) and duration of HIV infection (P = 0.005, OR = 2.282, 95% CI: 1.287–4.048) were significantly associated with active TB (Table 3).
Table 3

Characteristics of cases and controls.

VariableCases(n = 82) n(%)Controls (n = 82) n(%)P valueOR95% CI (for OR)
Occupation
    Farmer49 (59.8)57 (69.5)0.2411.4210.790–2.556
    Non-farmer33 (48.2)25 (30.5)
Ethnicity
    Han45 (54.9)48 (58.5)0.7251.3830.226–8.451
    Zhuang35 (42.7)31 (37.8)0.5721.6990.271–10.661
    Other*2 (2.4)3 (3.7)---
Education status
    Illiterate10 (12.2)10 (12.2)0.6731.3730.314–5.998
    Primary school38 (46.3)33 (40.2)0.3871.5660.566–4.350
    Junior middle school27 (32.9)29 (35.4)0.6721.2610.431–3.693
    Above high school*7 (8.5)10 (12.2)---
Marital status
    Married22 (26.8)30 (36.6)0.1361.8000.831–3.899
    Unmarried60(73.2)52 (63.4)
Place of Residence
    Urban area16 (19.5)10 (12.2)0.2070.5710.240–1.362
    Rural area66 (80.5)72 (87.8)
Local residence duration
    Less than 3 months28 (34.1)22 (26.8)0.1860.8480.664–1.083
    3–6 months4 (4.9)2 (2.4)
    6–12 months1 (1.2)1 (1.2)
    More than 12 months49 (59.8)57 (69.5)
Household incomes per capita, Yuan
    Less than 1 00012 (14.6)12 (14.6)1.0001.0000.489–2.046
    1 000–10 00066 (80.5)66 (80.5)
    More than 10 0004 (4.9)4 (4.9)
Number of family members
    none6 (7.3)12 (14.6)0.5120.8970.648–1.241
    two21 (25.6)14 (17.1)
    three33 (40.2)21 (25.6)
    Four or more22 (26.8)35 (42.7)
History of close contact with TB patient
    No78 (95.1)80 (97.6)0.4232.0000.366–10.919
    Yes4 (4.9)2 (2.4)
History of BCG vaccination
    No58 (70.7)55 (67.1)0.6020.8330.420–1.653
    Yes24 (29.3)27 (32.9)
History of former plasma donors
    No81 (98.8)82 (100.0)0.61065.2890.000–628084630.4
    Yes1 (1.2)0 (0.0)
History of intravenous drug
    No74 (90.2)74 (90.2)1.0001.0000.375–2.664
    Yes8 (9.8)8 (9.8)
HIV infect status of regular sex partner
    Positive11 (13.4)20 (24.4)0.0270.3060.107–0.876
    Negative17 (20.7)17 (20.7)0.3310.6460.268–1.560
    Unclear36 (43.9)26 (31.7)0.2080.5200.188–1.440
    Null information*18 (22.0)19 (23.2)---
Extramarital sex
    No19 (23.2)15 (18.3)0.4160.7140.317–1.608
    Yes63 (76.8)67 (81.7)
Status of condom using
    Frequent5 (6.1)3 (3.7)0.3852.0090.416–9.696
    Sometimes18 (22.0)20 (24.4)0.8011.1470.396–3.317
    Never40 (48.8)36 (43.9)0.4131.420.610–3.338
    Null information*19 (23.2)23 (28.0)---
History of drinking
    No68 (82.9)66 (80.5)0.6950.8570.396–1.853
    Yes14 (17.1)16 (19.5)
History of smoking
    No52 (63.4)66 (80.5)0.0232.2731.118–4.619
    Yes30 (36.6)16 (19.5)
BMI
    Less than 18.5 kg/m236 (43.9)27 (32.9)0.0440.5530.311–0.984
    18.5–24 kg/m244 (53.7)47 (57.3)
    More than 24 kg/m22 (2.4)8 (9.8)
Chronic disease
    No68 (82.9)72 (87.8)0.3961.4440.617–3.379
    Yes14 (17.1)10 (12.2)
Latest CD4+ T-cell count
    Less than 200 cell/mm327 (32.9)46 (56.1)0.0023.7141.612–8.577
    More than 200 cell/mm355 (67.1)36 (43.9)
HIV Risk Factors
    Sexual73 (89.0)71 (86.6)1.0001.0000.250–3.998
    Intravenous drug4 (4.9)6 (7.3)0.6720.6670.102–4.354
    Other*5 (6.1)5 (6.1)---
Status of ART
    No25 (30.5)51 (62.2)0.0003.8891.869–8.090
    Yes57 (69.5)31 (37.8)
Duration of HIV infection
    Less than 5 years13 (15.9)21 (25.6)0.0052.2821.287–4.048
    5–9 years45 (54.9)52 (63.4)
    More than 9 years24 (29.3)9 (11.0)

* reference for dummy raviable analysis

* reference for dummy raviable analysis On multivariate analysis for significant variables from univariate analysis, latest CD 4+ T-cell count (P = 0.025, OR = 3.288, 95% CI: 1.161–9.311), use of ART (P = 0.000, OR = 7.775, 95% CI: 2.618–23.094), history of smoking (P = 0.052, OR = 2.996, 95% CI 0.992–9.053) and duration of HIV infection (P = 0.000, OR = 5.946, 95% CI: 2.221–15.915) were independent risk factors for active TB in people living with HIV/AIDS (Table 4).
Table 4

Adjusted analysis for factors associated with TB.

VariableBWald valueP valueOR95% CI (for OR)
History of smoking1.0973.7840.0522.9960.992–9.053
Latest CD 4+ T-cell count1.1905.0240.0253.2881.161–9.311
Status of ART2.05113.6340.0007.7752.618–23.094
Duration of HIV infection1.78312.5920.0005.9462.221–15.915

Discussion

The risks factors associated with TB among people living with HIV/AIDS could generally be divided into two categories: biological and non-biological factors. It is clear about the biological factors. When MTB infects individuals infected with HIV, it can stimulate viral replication and accelerate HIV disease progression[10-12]. HIV infection can also make a person get active TB easier by inducing cytokines-Ⅱ[13]. However, external factors are very complicated. Social activities and environment can influence disease transmission and change their expected course. WHO published HIV/AIDS prevention and antiretroviral treatment guidelines in 2015 and strongly recommended that all individuals with HIV/AIDS should receive ART as soon as possible, regardless of CD4+ cell count[14]. ART not only can reduce the incidence of opportunistic infectious diseases (including TB), but also can prevent the secondary transmission of HIV. After diagnosis of TB, individuals should initiate ART in two to 8 weeks. Some cohort studies have shown that TB incidence decreased by 70~90% in HIV-infected subjects receiving ART[15-16]. Unfortunately, the surveillance population in our study sites had lower rate of ART use (47.4%). It is probably because of the lack of health knowledge and poor conditions in rural area. The multivariate analysis also showed an obvious difference between the ART recipients and the ones who were not receiving ART. The risk of TB disease among those who had not received ART was about 8 times higher than those who had received it (OR = 7.775). This indicates that the most effective way to prevent active TB in people living with HIV/AIDS is initiating ART as soon as possible. Physicians should monitor the indicators closely during the process of treatment for the occurrence of immune reconstitution inflammatory syndrome related TB[17]. Our study shows the significant correlation between lower CD 4+ T-cell count and active TB among HIV infected patients, as has been previously reported[18]. The risk of TB disease among those with CD 4+ T-cell counts less than 200 was 3 times higher than those with higher levels of CD 4+ T-cells (OR = 3.288). impaired immunity creates the prerequisite for mycobacterium tuberculosis infection., proliferation and spread. We should note that the onset of TB in an individual infected with HIV is insidious because of the impaired immune response[19]. Physicians often misdiagnose TB in those with mild clinical signs and atypical medical imaging. Another result of our research identified a long duration of HIV infection as another independent risk factors (OR = 5.946). As an incurable disease, AIDS can destroy the body’s defense system step by step. But some opportunistic infections can be prevented and controlled, including TB. So we suggest that medical institutions to provide regular TB screening every year, and increase the frequency of clinical evaluation for patients with longer duration of HIV infection and in those living with low CD 4+ T-cell counts, regardless of the presence of clinical symptoms. It is also necessary for patients with LTBI to received isoniazid preventive therapy (IPT) to avoid active TB[20]. In this study, we also focus on behavioral and clinical factors for TB in HIV-patients. The result of multivariable analysis shows a significant correlation between smoking and active TB among HIV infected individuals. This the same result has been observed in West Africa[21], Thailand[22], India[23] and China[24]. The possibility of active TB among smokers was 3 times that of non-smoking subjects in our study (OR = 2.996). Although the correlation between smoking and active TB remains controversial, two meta-analysis provide more evidence for the association between smoking and active TB[25-26]. At present, China is the largest consumer of tobacco worldwide. There are 350million smoking adults, and about 1 million people die each year from smoking related diseases[27]. Burning of tobacco produces at least 5 different known human carcinogens and a variety of toxic substances that can damage the respiratory mucociliary transport system and block the body’s removal of mycobacterium tuberculosis. Therefore, medical workers should strengthen the health education aspect of their daily work. Great efforts should be made to inform patients the dreadful consequences of smoking and encourage smokers to quit. This research detected active TB by multiple methods, including symptom screening, digital chest image, CT, sputum culture, Xpert-MTB/RIF Assay, IGRAs, histopathological examination and drug sensitivity or biochemical testing. This can help to increase the sensitivity for identifying active TB and LTBI in HIV-infected patients and excluding NTM. Thus we feel this result of prevalence rate is a credible estimate. One meta-analysis of active TB prevalence in HIV-infected patients in Mainland China (including 29 studies) from 2010 showed that the average prevalence rate was 7.2%[28]. In our research this rate was 15.6%, two-fold higher than the reported average rate. And this rate also higher than that in Yunnan, Sichuan and Henan[29]. The HIV infection rate among new active TB patients was also higher than the average rate in China[30]. As the area has double the disease burden, the TB/HIV co-infection situation is severe. Although the TB prevalence rate in the general population of Guangxi (about 90 cases/100 000 py)[31-32] is higher than that in USA (3.4 case/100 000 in 2011) [33]. this rate among HIV/AIDS population was 173 times higher than that in the general population of Guangxi. For decades, few studies have investigated the risk factors for active TB among HIV-infected patients in Guangxi. It is necessary for us to find the causes for this situation.

Limitations

There were some limitations in our research. First, as a pair-matched case-control study, it was difficult to select controls, especially in inpatient group. The inpatients with HIV were serious and maybe got another pulmonary opportunistic infectious disease except TB. So the individual with lung disease should be out. Next step, we may search the controls from outpatients. Second, as a retrospective study, there was a potential for bias and inaccurate data collection. A prospective cohort study would provide more complete data. Third, as a multivariable analysis, there may have been some risk factors we did not account for, such as awareness of TB and HIV, living environment and biological indicators.

Conclusion

The prevalence of TB among people living with HIV/AIDS in Guangxi was 173 times higher than general population in Guangxi. This is a severe public health problem in Guangxi. It is necessary for the government to integrate the treatment and control of the two diseases for optimal planning and resource allocation. Further strategies for the prevention and treatment among TB/HIV co-infected patients should be implemented. According to the multivariate analysis, the risk factors for active TB among people living with HIV/AIDS were smoking, lower CD 4+ T-cell count, long duration of HIV-infection and the lack of ART. We suggest that medical and public health workers should strengthen health education of TB/HIV prevention and treatment, and support smoking cessation. High frequency of TB surveillance and early initiation of ART is necessary, as is IPT and infection control in healthcare facilities.
  25 in total

1.  Sex work and risky sexual behaviors among foreign entertainment workers in urban Singapore: findings from Mystery Client Survey.

Authors:  Mee-Lian Wong; Roy Chan; Hiok Hee Tan; Eunice Yong; Lionel Lee; Jeffrey Cutter; Joanne Tay; David Koh
Journal:  J Urban Health       Date:  2012-12       Impact factor: 3.671

2.  Investigation of the risk factors for tuberculosis: a case-control study in three countries in West Africa.

Authors:  C Lienhardt; K Fielding; J S Sillah; B Bah; P Gustafson; D Warndorff; M Palayew; I Lisse; S Donkor; S Diallo; K Manneh; R Adegbola; P Aaby; O Bah-Sow; S Bennett; K McAdam
Journal:  Int J Epidemiol       Date:  2005-05-24       Impact factor: 7.196

3.  [Smoking and passive smoking in Chinese, 2002].

Authors:  Gong-huan Yang; Jie-min Ma; Na Liu; Ling-ni Zhou
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2005-02

4.  Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy.

Authors:  Guilherme Santoro-Lopes; Ana Maria Felix de Pinho; Lee H Harrison; Mauro Schechter
Journal:  Clin Infect Dis       Date:  2002-01-07       Impact factor: 9.079

5.  Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1.

Authors:  E Vicenzi; M Alfano; S Ghezzi; A Gatti; F Veglia; A Lazzarin; S Sozzani; A Mantovani; G Poli
Journal:  J Leukoc Biol       Date:  2000-09       Impact factor: 4.962

6.  Cytokine profile in human immunodeficiency virus positive patients with and without tuberculosis.

Authors:  S K Agarwal; A Singh; S Anuradha; N P Singh; J Sokhi; U K Baveja
Journal:  J Assoc Physicians India       Date:  2001-08

7.  HIV/TB co-infection in mainland China: a meta-analysis.

Authors:  Lei Gao; Feng Zhou; Xiangwei Li; Qi Jin
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

8.  Cigarette smoking and its relation to pulmonary tuberculosis in adults.

Authors:  Niorn Ariyothai; Amornrath Podhipak; Pasakorn Akarasewi; Songpol Tornee; Saijai Smithtikarn; Pittaya Thongprathum
Journal:  Southeast Asian J Trop Med Public Health       Date:  2004-03       Impact factor: 0.267

Review 9.  Tobacco and tuberculosis: a qualitative systematic review and meta-analysis.

Authors:  K Slama; C-Y Chiang; D A Enarson; K Hassmiller; A Fanning; P Gupta; C Ray
Journal:  Int J Tuberc Lung Dis       Date:  2007-10       Impact factor: 2.373

10.  Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007.

Authors:  Gry A Taarnhøj; Frederik N Engsig; Pernille Ravn; Isik S Johansen; Carsten S Larsen; Birgit Røge; Aase B Andersen; Niels Obel
Journal:  BMC Pulm Med       Date:  2011-05-23       Impact factor: 3.317

View more
  9 in total

1.  Magnitude and Associated Factors of Pulmonary Tuberculosis Among HIV/AIDS Patients Attending Antiretroviral Therapy Clinic at Debre Tabor Specialized Hospital, Northwest Ethiopia, 2019.

Authors:  Teklehaimanot Kiros; Eninur Dejen; Mulu Tiruneh; Tegenaw Tiruneh; Tahir Eyayu; Shewaneh Damtie; Kefyalew Amogne
Journal:  HIV AIDS (Auckl)       Date:  2020-12-03

2.  Xpert MTB/RIF assay for the diagnosis of Mycobacterium tuberculosis and Rifampicin resistance in high Human Immunodeficiency Virus setting in Gambella regional state, southwest Ethiopia.

Authors:  Eyasu Ejeta; Getenet Beyene; Zegeye Bonsa; Gemeda Abebe
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2018-06-14

3.  Types and prevalence of HIV-related opportunistic infections/conditions among HIV-positive patients attending Kenyatta National Hospital in Nairobi, Kenya.

Authors:  Geoffrey K Chepkondol; Pauline E Jolly; Nelly Yatich; Omar Mbowe; Walter G Jaoko
Journal:  Afr Health Sci       Date:  2020-06       Impact factor: 0.927

4.  Prevalence and incidence rate of tuberculosis among HIV-infected patients enrolled in HIV care, treatment, and support program in mainland Tanzania.

Authors:  M Majigo; G Somi; A Joachim; J Manyahi; J Nondi; V Sambu; A Rwebembera; N Makyao; A Ramadhani; W Maokola; J Todd; M I Matee
Journal:  Trop Med Health       Date:  2020-09-04

5.  The Effect of Long-Term HAART on the Incidence of Tuberculosis Among People Living with HIV in Addis Ababa, Ethiopia: A Matched Nested Case-Control Study.

Authors:  Ayinalem Alemu; Zebenay Workneh Bitew; Aman Yesuf; Betselot Zerihun; Melak Getu
Journal:  Infect Drug Resist       Date:  2021-12-06       Impact factor: 4.003

6.  Utilisation of village health workers' services for tuberculosis screening in Lesotho.

Authors:  Regina M Thetsane; Motšelisi Mokhethi; Maseabata Ramathebane; Nthatisi Leseba
Journal:  S Afr Fam Pract (2004)       Date:  2022-09-21

7.  Tuberculosis among Ambulatory People Living with HIV in Guangxi Province, China: A Longitudinal Study.

Authors:  Zhezhe Cui; Fei Huang; Dabin Liang; Yan Huang; Huifang Qin; Jing Ye; Liwen Huang; Chongxing Zhou; Minying Huang; Xiaoyan Liang; Fengxue Long; Yanlin Zhao; Mei Lin
Journal:  Int J Environ Res Public Health       Date:  2022-09-27       Impact factor: 4.614

8.  Effect of Isoniazid Prophylaxis Therapy on the Prevention of Tuberculosis Incidence and Associated Factors Among HIV Infected Individuals in Northwest Ethiopia: Retrospective Cohort Study.

Authors:  Mulat Addis Beshaw; Shitaye Alemu Balcha; Ayenew Molla Lakew
Journal:  HIV AIDS (Auckl)       Date:  2021-06-08

9.  A Case of Oral Histoplasmosis Concomitant with Pulmonary Tuberculosis.

Authors:  Silas Antonio Juvencio de Freitas Filho; Natália Galvão Garcia; Mário César de Souza; Denise Tostes Oliveira
Journal:  Case Rep Dent       Date:  2019-11-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.